Joseph C. Maggiore

Joseph C. Maggiore

Auto-generated profile, based on publicly available information

Joseph C. Maggiore

University of Pittsburgh

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in Communications Biology
Verified
Journal Article
Open access
PDF file
SDSuradip Das
Suradip Das
KBKevin D. Browne
Kevin D. Browne
FLFranco A. Laimo
Franco A. Laimo
JMJoseph C. Maggiore
Joseph C. Maggiore
MHMelanie C. Hilman
Melanie C. Hilman
DCD. Kacy Cullen
D. Kacy Cullen
Volumetric muscle loss (VML) is the traumatic or surgical loss of skeletal muscle beyond the inherent regenerative capacity of the body, generally leading to severe functional deficit. Formation of appropriate somato-motor innervations remains one of the biggest challenges for both autologous grafts as well as tissue-engineered muscle constructs. We aim to address this challenge by developing pre-innervated tissue-engineered muscle comprised of long aligned networks of spinal motor neurons and skeletal myocytes on aligned nanofibrous scaffolds. Motor neurons led to enhanced differentiation and maturation of skeletal myocytes in vitro. These pre-innervated tissue-engineered muscle constructs when implanted in a rat VML model significantly increased satellite cell density, neuromuscular junction maintenance, graft revascularization, and muscle volume over three weeks as compared to myocyte-only constructs and nanofiber scaffolds alone. These pro-regenerative effects may enhance functional neuromuscular regeneration following VML, thereby improving the levels of functional recovery following these devastating injuries.

18 June 2024 in Kidney International
Verified
Journal Article
Open access
JMJoseph C. Maggiore
Joseph C. Maggiore
RLRyan LeGraw
Ryan LeGraw
APAneta Przepiorski
Aneta Przepiorski
JVJeremy Velazquez
Jeremy Velazquez
CCChristopher Chaney
Christopher Chaney
NHNeil A. Hukriede
Neil A. Hukriede
Vascularization plays a critical role in organ maturation and cell-type development. Drug discovery, organ mimicry, and ultimately transplantation hinge on achieving robust vascularization of in vitro engineered organs. Here, focusing on human kidney organoids, we overcame this hurdle by combining a human induced pluripotent stem cell (iPSC) line containing an inducible ETS translocation variant 2 (ETV2) (a transcription factor playing a role in endothelial cell development) that directs endothelial differentiation in vitro, with a non-transgenic iPSC line in suspension organoid culture. The resulting human kidney organoids show extensive endothelialization with a cellular identity most closely related to human kidney endothelia. Endothelialized kidney organoids also show increased maturation of nephron structures, an associated fenestrated endothelium with de novo formation of glomerular and venous subtypes, and the emergence of drug-responsive renin expressing cells. The creation of an engineered vascular niche capable of improving kidney organoid maturation and cell type complexity is a significant step forward in the path to clinical translation. Thus, incorporation of an engineered endothelial niche into a previously published kidney organoid protocol allowed the orthogonal differentiation of endothelial and parenchymal cell types, demonstrating the potential for applicability to other basic and translational organoid studies.

8 March 2024 in Chest
Verified
Journal Article
Open access
LMLuca Molinari
Luca Molinari
GRGaspar Del Rio-Pertuz
Gaspar Del Rio-Pertuz
PPPriyanka Priyanka
Priyanka Priyanka
ASAli Smith
Ali Smith
JMJoseph C. Maggiore
Joseph C. Maggiore
JKJohn A Kellum
John A Kellum
Sepsis is the most common cause of acute kidney injury (AKI) in critically ill patients. Four phenotypes (α, β, γ, δ) for sepsis, which have different outcomes and responses to treatment, were described using routine clinical data in the electronic health record. Do the frequencies of AKI, acute kidney disease (AKD), chronic kidney disease (CKD), and AKI on CKD differ by sepsis phenotype? This was a secondary analysis of a randomized clinical trial of early resuscitation, including patients with septic shock at 31 sites. After excluding patients with end-stage kidney disease and missing data, we determined frequencies of the following clinical outcomes: AKI (defined within 24 h as Kidney Disease: Improving Global Outcomes stages 2 or 3 or stage 1 with tissue inhibitor of metalloproteinases-2 × insulin-like growth factor binding protein 7 value of > 2.0), CKD, and AKD (persistence of AKI at any stage on day 7 after enrollment) across four phenotypes. We performed multivariable logistic regression to assess the risk-adjusted association between development of AKI and AKD and phenotype. Among 1,090 eligible patients, 543 patients (50%) had AKI. Across phenotypes, the frequencies of AKI varied, being highest in the δ and β phenotypes (78% and 71%, respectively) and the lowest in the α phenotype (26%; P < .001). AKD occurred most often in the δ phenotype (41%) and least often in the α phenotype (8%; P < .001). The highest frequencies of CKD and of AKI on CKD were found in the β phenotype (53% and 38% respectively; P < .001 for both). In the multivariable logistic regression models (α phenotype as reference), δ phenotype showed the strongest association with AKI (OR, 12.33; 95% CI, 7.81-19.47; P < .001) and AKD (OR, 9.18; 95% CI, 5.44-15.51; P < .001). The rates of AKI and AKD differed across clinical sepsis phenotypes and are more common among patients with phenotypes β and δ. Phenotype β showed a higher level of underlying CKD that predisposed patients to new AKI. The α and γ phenotypes showed lower frequencies of AKI and less progression to AKD.

1 January 2024 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
BPBeatriz Maria Veloso Pereira
Beatriz Maria Veloso Pereira
YZYuting Zeng
Yuting Zeng
JMJoseph C. Maggiore
Joseph C. Maggiore
RSRobert Allen Schweickart
Robert Allen Schweickart
DEDiana G. Eng
Diana G. Eng
SSStuart J. Shankland
Stuart J. Shankland
Glomerular function is decreased by aging. However, little is known about the molecular mechanisms involved in age-related glomerular changes and which factors could contribute to a worse glomerular aging process. Here, we reported that podocyte injury in young mice and culture podocytes induced senescence, a marker of aging, and accelerates glomerular aging when compared with healthy aging mice.

1 October 2022 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
Nicolas MontalbettiNicolas Montalbetti
Nicolas Montalbetti
APAneta Przepiorski
Aneta Przepiorski
SSShujie Shi
Shujie Shi
SSShaohu Sheng
Shaohu Sheng
CBCatherine J. Baty
Catherine J. Baty
TKThomas Kleyman
Thomas Kleyman
Our results show that human kidney organoids express key K+ and Na+ channels that are expressed on the apical membranes of cells in the aldosterone-sensitive distal nephron, including the large-conductance Ca2+-activated K+ channel, renal outer medullary K+ channel, and epithelial Na+ channel.

30 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJoseph C. Maggiore
Joseph C. Maggiore
RLRyan LeGraw
Ryan LeGraw
APAneta Przepiorski
Aneta Przepiorski
JVJeremy Velazquez
Jeremy Velazquez
CCChristopher Chaney
Christopher Chaney
NHNeil A. Hukriede
Neil A. Hukriede
Vascularization plays a critical role in organ maturation and cell type development. Drug discovery, organ mimicry, and ultimately transplantation in a clinical setting thereby hinges on achieving robust vascularization of in vitro engineered organs. Here, focusing on human kidney organoids, we overcome this hurdle by combining an inducible ETS translocation variant 2 ( ETV2 ) human induced pluripotent stem cell (iPSC) line, which directs endothelial fate, with a non-transgenic iPSC line in suspension organoid culture. The resulting human kidney organoids show extensive vascularization by endothelial cells with an identity most closely related to endogenous kidney endothelia. Vascularized organoids also show increased maturation of nephron structures including more mature podocytes with improved marker expression, foot process interdigitation, an associated fenestrated endothelium, and the presence of renin + cells. The creation of an engineered vascular niche capable of improving kidney organoid maturation and cell type complexity is a significant step forward in the path to clinical translation. Furthermore, this approach is orthogonal to native tissue differentiation paths, hence readily adaptable to other organoid systems and thus has the potential for a broad impact on basic and translational organoid studies. Translational Statement: Developing therapies for patients with kidney diseases relies on a morphologically and physiologically representative in vitro model. Human kidney organoids are an attractive model to recapitulate kidney physiology, however, they are limited by the absence of a vascular network and mature cell populations. In this work, we have generated a genetically inducible endothelial niche that, when combined with an established kidney organoid protocol, induces the maturation of a robust endothelial cell network, induces a more mature podocyte population, and induces the emergence a functional renin population. This advance significantly increases the clinical relevance of human kidney organoids for etiological studies of kidney disease and future regenerative medicine strategies. Graphical Genetically engineered endothelial niche induces mature cell populations in human kidney organoids